Jarvik Gail P, Browning Brian L
Division of Medical Genetics, Department of Medicine and Department of Genome Sciences, The University of Washington, Seattle, WA 98195, USA.
Division of Medical Genetics, Department of Medicine and Department of Genome Sciences, The University of Washington, Seattle, WA 98195, USA.
Am J Hum Genet. 2016 Jun 2;98(6):1077-1081. doi: 10.1016/j.ajhg.2016.04.003. Epub 2016 May 26.
The American College of Medical Genetics and Genomics (ACMG) and Association of Molecular Pathology (AMP) recently published important new guidelines aiming to improve and standardize the pathogenicity classification of genomic variants. The Clinical Sequencing Exploratory Research (CSER) consortium evaluated the use of these guidelines across nine laboratories. One identified obstacle to consistent usage of the ACMG-AMP guidelines is the lack of a definition of cosegregation as criteria for pathogenicity classification. Cosegregation data differ from many other types of pathogenicity data in being quantitative. However, the ACMG-AMP guidelines do not define quantitative criteria for use of these data. Here, such quantitative criteria, in an easily implementable form, are proposed.
美国医学遗传学与基因组学学会(ACMG)和分子病理学协会(AMP)最近发布了重要的新指南,旨在改进和规范基因组变异的致病性分类。临床测序探索性研究(CSER)联盟评估了这九家实验室对这些指南的使用情况。ACMG-AMP指南在统一使用方面存在一个障碍,即缺乏将共分离作为致病性分类标准的定义。共分离数据在定量方面与许多其他类型的致病性数据不同。然而,ACMG-AMP指南并未定义使用这些数据的定量标准。在此,我们提出了一种易于实施的定量标准形式。